[1]
S. . Shalini, H. Mahajan, and M. B P, “INDIRECT COST AS HINDRANCE IN AVAILING DOTS FOR TUBERCULOSIS: IS THE TREATMENT TRULY FREE OF COST?”, Natl J Med Res, vol. 2, no. 01, pp. 35–38, Mar. 2012.